AKT2 and cancer: These mutations significantly disrupt key molecular mechanisms, including metal binding, loss of allosteric sites, and changes in post-translational modifications such as phosphorylation and glycosylation, potentially altering AKT2’s role in cellular signaling and contributing to cancer progression.